Breaking News Instant updates and real-time market news.

06:25
04/23/21
04/23
06:25
04/23/21
06:25

UBS chief economists to hold an analyst/industry conference call

Chief Economists Kapteyn & Donovan discuss new money vs old money and crypto vs gold on an Analyst/Industry conference call to be held on April 23 at 7 am.

TODAY'S FREE FLY STORIES

Hot Stocks
Iridium names Greg Pelton as new Chief Technical Officer » 08:10
06/14/21
06/14
08:10
06/14/21
08:10
IRDM

Iridium

$39.05 /

-0.34 (-0.86%)

Iridium announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IRDM Iridium
$39.05 /

-0.34 (-0.86%)

IRDM Iridium
$39.05 /

-0.34 (-0.86%)

04/05/21 William Blair
William Blair upgrades Gogo, sees shares going back to $13-$16
03/03/21
Fly Intel: Top five analyst upgrades
03/03/21 Raymond James
Iridium upgraded to Outperform from Market Perform at Raymond James
03/03/21 Raymond James
Iridium upgraded to Outperform from Market Perform at Raymond James
IRDM Iridium
$39.05 /

-0.34 (-0.86%)

Hot Stocks
Standard Lithium announces early conversion of loan facility with LANXESS » 08:10
06/14/21
06/14
08:10
06/14/21
08:10
STLHF

Standard Lithium

$3.10 /

+0.035 (+1.14%)

Standard Lithium…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
STLHF Standard Lithium
$3.10 /

+0.035 (+1.14%)

STLHF Standard Lithium
$3.10 /

+0.035 (+1.14%)

01/12/21 Canaccord
Standard Lithium initiated with a Speculative Buy at Canaccord
Initiation
Procore initiated with a Buy, $100 target at Canaccord » 08:10
06/14/21
06/14
08:10
06/14/21
08:10
PCOR

Procore

$83.98 /

-2.47 (-2.86%)

Canaccord analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PCOR Procore
$83.98 /

-2.47 (-2.86%)

07:21 Today JPMorgan
Procore initiated with an Overweight at JPMorgan
07:04 Today William Blair
Procore initiated with an Outperform at William Blair
06:21 Today Canaccord
Procore initiated with a Buy at Canaccord
06:15 Today Oppenheimer
Procore initiated with an Outperform at Oppenheimer
  • 20
    May
PCOR Procore
$83.98 /

-2.47 (-2.86%)

PCOR Procore
$83.98 /

-2.47 (-2.86%)

Hot Stocks
Addus HomeCare announces Robby Stevenson as Chief Human Resource Officer » 08:09
06/14/21
06/14
08:09
06/14/21
08:09
ADUS

Addus HomeCare

$90.89 /

-1.33 (-1.44%)

Addus HomeCare announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADUS Addus HomeCare
$90.89 /

-1.33 (-1.44%)

ADUS Addus HomeCare
$90.89 /

-1.33 (-1.44%)

08/12/20 BMO Capital
Addus HomeCare price target raised to $115 from $103 at BMO Capital
08/11/20 Oppenheimer
Addus HomeCare price target raised to $115 from $107 at Oppenheimer
06/17/20 Baird
Addus HomeCare price target raised to $100 from $96 at Baird
ADUS Addus HomeCare
$90.89 /

-1.33 (-1.44%)

  • 08
    Dec
  • 13
    Aug
ADUS Addus HomeCare
$90.89 /

-1.33 (-1.44%)

Hot Stocks
Aligos Therapeutics: CAM candidate, STOPS candidate complete Phase 1a studies » 08:08
06/14/21
06/14
08:08
06/14/21
08:08
AGLS

Aligos Therapeutics

$19.38 /

+ (+0.00%)

Aligos Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Phunware set to join Russell Microcap Index » 08:07
06/14/21
06/14
08:07
06/14/21
08:07
PHUN

Phunware

$1.40 /

+0.02 (+1.45%)

Phunware is set to join…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PHUN Phunware
$1.40 /

+0.02 (+1.45%)

PHUN Phunware
$1.40 /

+0.02 (+1.45%)

05/11/21 Roth Capital
Phunware initiated with a Buy at Roth Capital
06/16/20 Ascendiant
Ascendiant starts Phunware with Buy rating, $4 price target
06/16/20 Ascendiant
Phunware initiated with a Buy at Ascendiant
PHUN Phunware
$1.40 /

+0.02 (+1.45%)

  • 12
    Feb
Hot Stocks
Lipocine: FDA Clears LPCN 1154 IND application for Phase 2 postpartum study » 08:07
06/14/21
06/14
08:07
06/14/21
08:07
LPCN

Lipocine

$1.33 /

+0.065 (+5.16%)

Lipocine announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LPCN Lipocine
$1.33 /

+0.065 (+5.16%)

LPCN Lipocine
$1.33 /

+0.065 (+5.16%)

12/10/20 Ladenburg
Lipocine upgraded to Buy after tentative Tlando approval at Ladenburg
12/10/20 Ladenburg
Lipocine upgraded to Buy from Neutral at Ladenburg
  • 26
    Jan
LPCN Lipocine
$1.33 /

+0.065 (+5.16%)

Initiation
Original Bark Company initiated with a Buy at Canaccord » 08:07
06/14/21
06/14
08:07
06/14/21
08:07
BARK

Original Bark Company

$11.87 /

-0.5 (-4.04%)

Canaccord Genuity analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BARK Original Bark Company
$11.87 /

-0.5 (-4.04%)

06/10/21
Fly Intel: Top five analyst initiations
06/10/21 Jefferies
Barkbox initiated with a Buy at Jefferies
BARK Original Bark Company
$11.87 /

-0.5 (-4.04%)

BARK Original Bark Company
$11.87 /

-0.5 (-4.04%)

Hot Stocks
Rapt Therapeutics reports 'positive' results from Phase 1b RPT193 trial » 08:07
06/14/21
06/14
08:07
06/14/21
08:07
RAPT

Rapt Therapeutics

$18.57 /

-0.15 (-0.80%)

RAPT Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RAPT Rapt Therapeutics
$18.57 /

-0.15 (-0.80%)

RAPT Rapt Therapeutics
$18.57 /

-0.15 (-0.80%)

05/17/21 H.C. Wainwright
Rapt Therapeutics price target lowered to $29 from $32 at H.C. Wainwright
04/12/21 Roth Capital
Roth says Rapt Therapeutics' AACR presentations highlight broad potential
03/12/21 H.C. Wainwright
Rapt Therapeutics price target raised to $32 from $30 at H.C. Wainwright
11/17/20 BMO Capital
Rapt Therapeutics price target lowered to $45 from $51 at BMO Capital
RAPT Rapt Therapeutics
$18.57 /

-0.15 (-0.80%)

Hot Stocks
Twist Bioscience collaborates with Regeneron for genotyping assay production » 08:07
06/14/21
06/14
08:07
06/14/21
08:07
TWST

Twist Bioscience

$114.75 /

+2.95 (+2.64%)

, REGN

Regeneron

$525.71 /

-6.63 (-1.25%)

Twist Bioscience (TWST)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TWST Twist Bioscience
$114.75 /

+2.95 (+2.64%)

REGN Regeneron
$525.71 /

-6.63 (-1.25%)

TWST Twist Bioscience
$114.75 /

+2.95 (+2.64%)

06/04/21
Fly Intel: Top five analyst initiations
06/04/21 Goldman Sachs
Twist Bioscience initiated with a Neutral at Goldman Sachs
05/11/21 Piper Sandler
Twist Bioscience recent weakness a buying opportunity, says Piper Sandler
04/12/21
Fly Intel: Top five analyst initiations
REGN Regeneron
$525.71 /

-6.63 (-1.25%)

07:32 Today Argus
Regeneron's multiple bullish signals suggest return to growth, says Argus
05/13/21 Needham
Graybug Vision downgraded to Hold from Buy at Needham
05/07/21 Morgan Stanley
Regeneron price target raised to $495 from $477 at Morgan Stanley
05/06/21 Piper Sandler
Regeneron remains top large cap pick, says Piper Sandler
TWST Twist Bioscience
$114.75 /

+2.95 (+2.64%)

REGN Regeneron
$525.71 /

-6.63 (-1.25%)

  • 03
    Dec
REGN Regeneron
$525.71 /

-6.63 (-1.25%)

TWST Twist Bioscience
$114.75 /

+2.95 (+2.64%)

REGN Regeneron
$525.71 /

-6.63 (-1.25%)

REGN Regeneron
$525.71 /

-6.63 (-1.25%)

Hot Stocks
Clever Leaves to join Russell Microcap Index » 08:06
06/14/21
06/14
08:06
06/14/21
08:06
CLVR

Clever Leaves

$11.44 /

+0.63 (+5.83%)

Clever Leaves announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CLVR Clever Leaves
$11.44 /

+0.63 (+5.83%)

CLVR Clever Leaves
$11.44 /

+0.63 (+5.83%)

CLVR Clever Leaves
$11.44 /

+0.63 (+5.83%)

Earnings
Motorcar Parts reports Q4 EPS 4c, consensus 64c » 08:06
06/14/21
06/14
08:06
06/14/21
08:06
MPAA

Motorcar Parts

$23.24 /

-0.09 (-0.39%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MPAA Motorcar Parts
$23.24 /

-0.09 (-0.39%)

MPAA Motorcar Parts
$23.24 /

-0.09 (-0.39%)

02/04/21 B. Riley Securities
Motorcar Parts price target raised to $28 from $25 at B. Riley Securities
08/11/20 Craig-Hallum
Motorcar Parts downgraded to Hold from Buy at Craig-Hallum
07/01/20 B. Riley FBR
Motorcar Parts transferred with Buy rating at B. Riley FBR
06/19/20 Roth Capital
Motorcar Parts assumed with a Buy at Roth Capital
MPAA Motorcar Parts
$23.24 /

-0.09 (-0.39%)

Hot Stocks
IMAC acquires Fort Pierce Chiropractic for undisclosed amount » 08:05
06/14/21
06/14
08:05
06/14/21
08:05
IMAC

IMAC

$1.98 /

-0.045 (-2.23%)

IMAC Holdings announces…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IMAC IMAC
$1.98 /

-0.045 (-2.23%)

IMAC IMAC
$1.98 /

-0.045 (-2.23%)

04/09/21 Alliance Global Partners
IMAC price target lowered to $2.35 from $3.10 at Alliance Global Partners
11/17/20 Alliance Global Partners
IMAC initiated with a Buy at Alliance Global Partners
IMAC IMAC
$1.98 /

-0.045 (-2.23%)

  • 18
    Jun
Hot Stocks
iCAD's ProFound AI DBT receives CE Mark approval » 08:05
06/14/21
06/14
08:05
06/14/21
08:05
ICAD

iCAD

$18.48 /

+0.1 (+0.54%)

iCAD announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ICAD iCAD
$18.48 /

+0.1 (+0.54%)

ICAD iCAD
$18.48 /

+0.1 (+0.54%)

04/22/21 Guggenheim
iCAD initiated with a Buy at Guggenheim
03/23/21 BTIG
iCAD initiated with a Buy at BTIG
03/23/21 BTIG
iCAD initiated with a Buy at BTIG
02/26/21 B. Riley Securities
iCAD price target raised to $23 from $18 at B. Riley Securities
ICAD iCAD
$18.48 /

+0.1 (+0.54%)

  • 03
    Mar
ICAD iCAD
$18.48 /

+0.1 (+0.54%)

Hot Stocks
Happiness Biotech unit signs agreement to distribute Volkswagen EVs » 08:05
06/14/21
06/14
08:05
06/14/21
08:05
HAPP

Happiness Biotech

$1.67 /

-0.02 (-1.18%)

, VWAGY

Volkswagen

$36.21 /

+0.21 (+0.58%)

Happiness Biotech (HAPP)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HAPP Happiness Biotech
$1.67 /

-0.02 (-1.18%)

VWAGY Volkswagen
$36.21 /

+0.21 (+0.58%)

HAPP Happiness Biotech
$1.67 /

-0.02 (-1.18%)

VWAGY Volkswagen
$36.21 /

+0.21 (+0.58%)

05/20/21 Citi
Volkswagen resumed with a Buy at Citi
05/10/21 Wedbush
Tesla demand looks robust so far in Q2 despite rising competition, says Wedbush
05/07/21 JPMorgan
Volkswagen price target lowered to EUR 245 from EUR 255 at JPMorgan
05/07/21 RBC Capital
Volkswagen price target raised to EUR 290 from EUR 277 at RBC Capital
VWAGY Volkswagen
$36.21 /

+0.21 (+0.58%)

VWAGY Volkswagen
$36.21 /

+0.21 (+0.58%)

VWAGY Volkswagen
$36.21 /

+0.21 (+0.58%)

Hot Stocks
Exelixis, Bristol-Myers enter supply agreement for STELLAR-002 trial » 08:05
06/14/21
06/14
08:05
06/14/21
08:05
EXEL

Exelixis

$22.98 /

+0.01 (+0.04%)

, BMY

Bristol-Myers

$67.35 /

-0.03 (-0.04%)

, NKTR

Nektar

$17.62 /

-0.22 (-1.23%)

Exelixis (EXEL) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EXEL Exelixis
$22.98 /

+0.01 (+0.04%)

BMY Bristol-Myers
$67.35 /

-0.03 (-0.04%)

NKTR Nektar
$17.62 /

-0.22 (-1.23%)

EXEL Exelixis
$22.98 /

+0.01 (+0.04%)

05/25/21 Stifel
Exelixis' COSMIC-021 cohort 6 results 'incrementally negative,' says Stifel
05/18/21 Goldman Sachs
Exelixis assumed with a Sell at Goldman Sachs
03/30/21 Credit Suisse
Exelixis initiated with an Outperform at Credit Suisse
03/30/21 Credit Suisse
Exelixis initiated with an Outperform at Credit Suisse
BMY Bristol-Myers
$67.35 /

-0.03 (-0.04%)

05/05/21 Wells Fargo
Wells sees 'limited impact' on Iovance's lifileucel from Keytruda/Yervoy data
04/30/21
Fly Intel: Top five analyst downgrades
04/30/21 Morgan Stanley
Bristol-Myers downgraded to Equal Weight on pipeline questions at Morgan Stanley
04/30/21 Morgan Stanley
Bristol-Myers downgraded to Equal Weight from Overweight at Morgan Stanley
NKTR Nektar
$17.62 /

-0.22 (-1.23%)

05/18/21 Goldman Sachs
Nektar assumed with a Neutral at Goldman Sachs
02/22/21 Benchmark
Nektar downgraded to Hold on valuation at Benchmark
02/22/21 Benchmark
Nektar downgraded to Hold from Buy at Benchmark
02/17/21 William Blair
William Blair 'highly encouraged' by Nektar's collaborations with Merk, SFJ
EXEL Exelixis
$22.98 /

+0.01 (+0.04%)

BMY Bristol-Myers
$67.35 /

-0.03 (-0.04%)

NKTR Nektar
$17.62 /

-0.22 (-1.23%)

BMY Bristol-Myers
$67.35 /

-0.03 (-0.04%)

EXEL Exelixis
$22.98 /

+0.01 (+0.04%)

BMY Bristol-Myers
$67.35 /

-0.03 (-0.04%)

BMY Bristol-Myers
$67.35 /

-0.03 (-0.04%)

Hot Stocks
MDC Partners receives revised offer from Stagwell Media » 08:03
06/14/21
06/14
08:03
06/14/21
08:03
MDCA

MDC Partners

$5.58 /

+0.26 (+4.89%)

MDC Partners announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MDCA MDC Partners
$5.58 /

+0.26 (+4.89%)

MDCA MDC Partners
$5.58 /

+0.26 (+4.89%)

Hot Stocks
GCM Grosvenor announces $85M upsizing of term loan » 08:02
06/14/21
06/14
08:02
06/14/21
08:02
GCMG

GCM Grosvenor

$10.20 /

-0.33 (-3.13%)

GCM Grosvenor announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GCMG GCM Grosvenor
$10.20 /

-0.33 (-3.13%)

GCMG GCM Grosvenor
$10.20 /

-0.33 (-3.13%)

04/23/21 JPMorgan
JPMorgan double upgrades GCM Grosvenor on improved fundraising
04/23/21 JPMorgan
GCM Grosvenor upgraded to Overweight from Underweight at JPMorgan
12/14/20 JPMorgan
GCM Grosvenor initiated with an Underweight at JPMorgan
11/30/20 William Blair
GCM Grosvenor initiated with an Outperform at William Blair
GCMG GCM Grosvenor
$10.20 /

-0.33 (-3.13%)

Recommendations
Equitable Holdings price target raised to $51 from $42 at Credit Suisse » 08:02
06/14/21
06/14
08:02
06/14/21
08:02
EQH

Equitable Holdings

$31.16 /

+0.84 (+2.77%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EQH Equitable Holdings
$31.16 /

+0.84 (+2.77%)

EQH Equitable Holdings
$31.16 /

+0.84 (+2.77%)

05/11/21 Truist
Equitable Holdings price target raised to $43 from $37 at Truist
04/20/21 UBS
Equitable Holdings initiated with a Buy at UBS
04/05/21 JPMorgan
Equitable Holdings price target raised to $32 from $27 at JPMorgan
03/31/21 Citi
Equitable Holdings price target raised to $38 from $34 at Citi
EQH Equitable Holdings
$31.16 /

+0.84 (+2.77%)

Recommendations
DHI Group transferred with Buy, $4.50 target at B. Riley » 08:01
06/14/21
06/14
08:01
06/14/21
08:01
DHX

DHI Group

$3.65 /

+0.3 (+8.96%)

B. Riley analyst Zach…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DHX DHI Group
$3.65 /

+0.3 (+8.96%)

DHX DHI Group
$3.65 /

+0.3 (+8.96%)

Hot Stocks
Opthea appoints Adams as company secretary, vice president of France » 08:00
06/14/21
06/14
08:00
06/14/21
08:00
OPT

Opthea

$9.50 /

+0.45 (+4.97%)

Opthea Limited announces…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OPT Opthea
$9.50 /

+0.45 (+4.97%)

OPT Opthea
$9.50 /

+0.45 (+4.97%)

11/17/20 Citi
Opthea initiated with a Buy at Citi
11/11/20 SVB Leerink
SVB Leerink bullish on Opthea, initiates with an Outperform
11/11/20 SVB Leerink
Opthea initiated with an Outperform at SVB Leerink
11/11/20 Oppenheimer
Opthea initiated with an Outperform at Oppenheimer
  • 16
    Oct
Options
AMC Entertainment call buyer realizes 29% same-day gains » 08:00
06/14/21
06/14
08:00
06/14/21
08:00
AMC

AMC Entertainment

$49.32 /

+6.435 (+15.01%)

Notable profits for the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMC AMC Entertainment
$49.32 /

+6.435 (+15.01%)

AMC AMC Entertainment
$49.32 /

+6.435 (+15.01%)

06/08/21 MKM Partners
AMC Entertainment shareholders best served by lower debt, says MKM Partners
06/07/21 B. Riley
Box office trends improving into summer, says B. Riley
06/04/21 BofA
BofA moves to No Rating on Bed Bath & Beyond amid 'meme mania'
06/04/21 Wedbush
AMC Entertainment price target raised to $7.50 from $6.50 at Wedbush
AMC AMC Entertainment
$49.32 /

+6.435 (+15.01%)

AMC AMC Entertainment
$49.32 /

+6.435 (+15.01%)

AMC AMC Entertainment
$49.32 /

+6.435 (+15.01%)

AMC AMC Entertainment
$49.32 /

+6.435 (+15.01%)

Hot Stocks
Yumanity Therapeutics appoints Devin Smith as general counsel » 07:59
06/14/21
06/14
07:59
06/14/21
07:59
YMTX

Yumanity Therapeutics

$16.18 /

+0.445 (+2.83%)

, NERV

Minerva

$2.90 /

-0.19 (-6.15%)

Yumanity Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
YMTX Yumanity Therapeutics
$16.18 /

+0.445 (+2.83%)

NERV Minerva
$2.90 /

-0.19 (-6.15%)

YMTX Yumanity Therapeutics
$16.18 /

+0.445 (+2.83%)

06/04/21 H.C. Wainwright
Yumanity Therapeutics initiated with a Buy at H.C. Wainwright
04/01/21 Jefferies
Yumanity Therapeutics initiated with a Buy at Jefferies
01/05/21 Piper Sandler
Piper wants to own Yumanity with shares turning corner post merger
12/23/20 Piper Sandler
Piper updates Yumanity Therapeutics price target to $36 after merger completion
NERV Minerva
$2.90 /

-0.19 (-6.15%)

03/08/21 JMP Securities
JMP Securities remains bullish on Minerva after results, ahead of OLE results
12/01/20 JMP Securities
Minerva laid out path to roluperidone submission, says JMP Securities
07/01/20 JMP Securities
Minerva's seltorexant still 'underappreciated' upside driver, says JMP
YMTX Yumanity Therapeutics
$16.18 /

+0.445 (+2.83%)

NERV Minerva
$2.90 /

-0.19 (-6.15%)

YMTX Yumanity Therapeutics
$16.18 /

+0.445 (+2.83%)

Recommendations
Olin price target raised to $69 from $55 at Wells Fargo » 07:58
06/14/21
06/14
07:58
06/14/21
07:58
OLN

Olin

$48.82 /

+0.59 (+1.22%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OLN Olin
$48.82 /

+0.59 (+1.22%)

OLN Olin
$48.82 /

+0.59 (+1.22%)

06/11/21 JPMorgan
Olin price target raised to $61 from $51 at JPMorgan
06/09/21 Wolfe Research
Olin initiated with an Outperform at Wolfe Research
04/29/21 Vertical Research
Olin upgraded to Buy from Hold at Vertical Research
04/29/21 Wells Fargo
Olin price target raised to $55 from $50 at Wells Fargo
OLN Olin
$48.82 /

+0.59 (+1.22%)

OLN Olin
$48.82 /

+0.59 (+1.22%)

Initiation
iMedia Brands initiated with a Buy, $22 target at B. Riley » 07:58
06/14/21
06/14
07:58
06/14/21
07:58
IMBI

iMedia Brands

$8.72 /

-0.28 (-3.11%)

B. Riley analyst Eric…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IMBI iMedia Brands
$8.72 /

-0.28 (-3.11%)

IMBI iMedia Brands
$8.72 /

-0.28 (-3.11%)

07:28 Today B. Riley
iMedia Brands initiated with a Buy at B. Riley
05/26/21 Lake Street
iMedia Brands price target raised to $19 from $15 at Lake Street
05/25/21 Craig-Hallum
iMedia Brands price target raised to $20 from $15 at Craig-Hallum
03/23/21 Lake Street
iMedia Brands price target raised to $15 from $13 at Lake Street
IMBI iMedia Brands
$8.72 /

-0.28 (-3.11%)

  • 10
    Jun
  • 18
    Feb
  • 26
    Aug
IMBI iMedia Brands
$8.72 /

-0.28 (-3.11%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.